Literature DB >> 17848275

Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update.

Jean-Pierre Pignon1, Aurélie le Maître, Jean Bourhis.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17848275     DOI： 10.1016/j.ijrobp.2007.04.088

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  67 in total

Review 1.  Current concepts of organ preservation in head and neck cancer.

Authors:  C-J Wang; R Knecht
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-11-25       Impact factor: 2.503

2.  Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptors.

Authors:  Tim J Kruser; Deric L Wheeler; Eric A Armstrong; Mari Iida; Kevin R Kozak; Albert J van der Kogel; Johan Bussink; Angela Coxon; Anthony Polverino; Paul M Harari
Journal:  Clin Cancer Res       Date:  2010-05-27       Impact factor: 12.531

3.  [Progression-free survival of patients with locally advanced NSCLC not improved by consolidation chemotherapy after concurrent chemoradiation].

Authors:  Nadja Ebert; Michael Baumann
Journal:  Strahlenther Onkol       Date:  2016-02       Impact factor: 3.621

Review 4.  Photodynamic therapy in the management of pre-malignant head and neck mucosal dysplasia and microinvasive carcinoma.

Authors:  Harry Quon; Craig E Grossman; Jarod C Finlay; Timothy C Zhu; Clarice S Clemmens; Kelly M Malloy; Theresa M Busch
Journal:  Photodiagnosis Photodyn Ther       Date:  2011-06       Impact factor: 3.631

Review 5.  [Radiotherapy of lymph node metastases].

Authors:  M Stuschke
Journal:  Urologe A       Date:  2009-01       Impact factor: 0.639

6.  Acetylated tubulin (AT) as a prognostic marker in squamous cell carcinoma of the head and neck.

Authors:  Nabil F Saba; Kelly R Magliocca; Sungjin Kim; Susan Muller; Zhengjia Chen; Taofeek K Owonikoko; Nicholas J Sarlis; Carrie Eggers; Vanessa Phelan; William J Grist; Amy Y Chen; Suresh S Ramalingam; Zhuo G Chen; Jonathan J Beitler; Dong M Shin; Fadlo R Khuri; Adam I Marcus
Journal:  Head Neck Pathol       Date:  2013-07-24

Review 7.  Management of head and neck cancer in elderly patients.

Authors:  Yassine Lalami; Gilberto de Castro; Chantal Bernard-Marty; Ahmad Awada
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

8.  Concurrent hyperfractionated accelerated radiotherapy with 5-FU and once weekly cisplatin in locally advanced head and neck cancer. The 10-year results of a prospective phase II trial.

Authors:  V Budach; E-T Becker; D Boehmer; H Badakhshi; U Jahn; K-D Wernecke; C Stromberger
Journal:  Strahlenther Onkol       Date:  2013-12-11       Impact factor: 3.621

9.  Radical radiotherapy with concurrent weekly cisplatin in loco-regionally advanced squamous cell carcinoma of the head and neck: a single-institution experience.

Authors:  Tejpal Gupta; Jai Prakash Agarwal; Sarbani Ghosh-Laskar; Purvish M Parikh; Anil K D'Cruz; Ketayun A Dinshaw
Journal:  Head Neck Oncol       Date:  2009-06-15

10.  Pretreatment organ function in patients with advanced head and neck cancer: clinical outcome measures and patients' views.

Authors:  Lisette van der Molen; Maya A van Rossum; Annemieke H Ackerstaff; Ludi E Smeele; Coen R N Rasch; Frans J M Hilgers
Journal:  BMC Ear Nose Throat Disord       Date:  2009-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.